PA
SB icon

PharVision Advisers’s Safe Bulkers SB Stock Holding History

PharVision Advisers’s Portfolio SB Stock Details SB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Sell
16,505
-8,528
-34% -$57K 1.96% 15
2026
Q1 		$158K Buy
+25,033
New +$146K 1.61% 9

Other funds holding SB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
FAM
Fearnley Asset Management Oslo $278M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

PharVision Advisers's SB Position: Q2 2026 in Review

PharVision Advisers reduced its Safe Bulkers (SB) stake by 34% in Q2 2026, selling an estimated $57K and leaving 16,505 shares worth $104K. The position accounts for 1.96% of the portfolio, ranked #15.

PharVision Advisers first reported a position in SB in Q1 2026 and has held it in 2 quarters since. The position peaked at $158K in Q1 2026. 160 funds tracked by Wall St. Rank hold SB as of Q2 2026.

  • PharVision Advisers held 16,505 shares of Safe Bulkers worth $104K as of Q2 2026.
  • PharVision Advisers sold 8,528 Safe Bulkers shares in Q2 2026, an estimated $57K.
  • Safe Bulkers made up 1.96% of PharVision Advisers's portfolio in Q2 2026, its #15 holding.
  • PharVision Advisers first reported a position in Safe Bulkers in Q1 2026 and has held it in 2 quarters since.
  • PharVision Advisers's Safe Bulkers position peaked at $158K in Q1 2026.
  • 160 funds tracked by Wall St. Rank held Safe Bulkers as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.